Fundraising Fox

Mario Barro

Investor

Venture Partner at RA Capital · Board director at ILiAD Biotechnologies · President & CEO at GIVAX

Vienna, Virginia, United States

Find your path to Mario

413 people in our graph share verified history with Mario — schools, employers, funds. One of them is your warm intro.

Uri LopatinunlockedMario: together at NIH (2003–2007)
×2Mario: together at RA Capital
×5Mario: together at Sanofi Pasteur
×2Mario: together at NIH

About

Mario Barro is an Entrepreneur in Residence at RAVen (RA Ventures) and VP of Early Discovery at Neuro StealthCo, with over 14 years of experience in small molecule drug discovery. His background in medicinal chemistry spans neurodegeneration and psychotherapeutics, including work on LRRK2, TTBK1, GBA, and a range of GPCR and SLC projects, following prior roles at Biogen, Pfizer, and Jnana Therapeutics. He is co-inventor of three clinical-stage assets, including Tavapadon, a D1 agonist in Phase 3 trials for Parkinson's disease.

Board director at ILiAD Biotechnologies

Intro paths

→

In turn, Mario can intro founders to ILiAD Biotechnologies's investors below.

ILiAD Biotechnologies's investors · 1

RA CapitalBoston

Co-founders at ILiAD Biotechnologies

KRKeith Rubin
Keith RubinExecutive Officer, Director

President & CEO at GIVAX

Intro paths

→

In turn, Mario can intro founders to GIVAX's investors below.

GIVAX's investors · 1

RA CapitalBoston

Co-founders at GIVAX

JPJohn Patton
John PattonScientific Co-Founder

Experience

  1. RA Capital ManagementVenture Partner and Head of Infectious Diseases at RA Capitalcurrent2021 — presentBoston, Massachusetts, United States
  2. GIVAX, Inc.CEO & President GIVAXcurrent2021 — present
  3. Curevo VaccineMember Board of Directors at Curevocurrent2021 — present
  4. Vaxess TechnologiesMember Board Of Directors2021 — 2024Boston, Massachusetts, United States
  5. RA VenturesDirector2021 — 2022Boston, Massachusetts, United States
  6. Sanofi PasteurAVP2018 — 2021Cambridge, MA
  7. Sanofi PasteurAVP. Head of Advanced Research2018 — 2021Cambridge United States
  8. Sanofi PasteurSr. Director, Innovation2016 — 2018Washington DC-Baltimore Area
  9. Influenza and EID at BARDA, HHS/OS/ASPRInterdisciplinary Scientist. Project Officer. Contracting Officer’s Technical Representative III.2011 — 2016Washington DC
  10. Global Vaccines, Inc.Director of Research2010 — 2011Research Triangle Park NC
  11. Global Vaccines, Inc.Lead Scientist2007 — 2010
  12. FreelanceConsultant2007 — 2010Chapel Hill, North Carolina
  13. NIHPost Doctoral Fellow2003 — 2007
  14. Mount Sinai School of MedicinePost Doctoral Fellow2001 — 2002
  15. Department of Biology. Laboratory of Virology. Universidad de Santiago de Chile. Chile.Research Fellow.1997 — 2001
  16. FreelanceConsultant1996 — 2001Santiago de Chile, Chile
  17. Molecular Biology Department. Cancer Institute. Havana, Cuba.Scientist1994 — 1996
  18. Infectious Diseases Division. Center of Genetic Engineering and Biotechnology, Havana, Cuba.Scientist1990 — 1994

Skills & more

InvestmentsVirology50Viral Vectors3Vaccines43Molecular Biology63Immunology60Program Management3Adjuvants1Preclinical Research1Animal Models14Innate Immunity2Bioinformatics12
+8 moreAssay DevelopmentBiotechnologySequencingR&DProtein ChemistryScienceAntibodiesClinical Development

Languages English · Russian · Spanish

  • Contract Officer Technical Representative III (COTR)

From Mario's professional profile.

Colleagues at RA Capital

Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital

Frequently asked questions

Who is Mario Barro?
Mario Barro is an Entrepreneur in Residence at RAVen (RA Ventures) and VP of Early Discovery at Neuro StealthCo, with over 14 years of experience in small molecule drug discovery. His background in medicinal chemistry spans neurodegeneration and psychotherapeutics, including work on LRRK2, TTBK1, GBA, and a range of GPCR and SLC projects, following prior roles at Biogen, Pfizer, and Jnana Therapeutics. He is co-inventor of three clinical-stage assets, including Tavapadon, a D1 agonist in Phase 3 trials for Parkinson's disease.
Where does Mario Barro work?
Mario Barro is Venture Partner at RA Capital and Board director at ILiAD Biotechnologies and President & CEO at GIVAX.
Where did Mario Barro go to school?
Mario Barro studied at Universidad de Chile (PhD, Virology and Microbiology); Belarusian State University & University of Havana, Cuba. (MS, Physics).

Founder mafias

Universidad de Chile mafia25

Also came through, then founded or led a company.

Omar LarréMathematical Engineering Title (Masters Equivalent)Founded Fintual +1Tillmann LangFounded Yova +1Eduardo AbeliukBS/EngFounded TeselaGenLuis VeraIndustrial EngineerFounded ZippediPedro PinedaLicenciado en GeofísicaFounded FintualFrancisco TorrealbaB.S. in EconomicsFounded Blissway

+ 18 more

RA Capital mafia5

Also came through, then founded or led a company.

Josh ResnickPartnerFounded Mariana Oncology +1Adam CottonConsultantFounded Epi BiologicsEmily MinkowManaging Director, VentureFounded Stylus MedicineRisa StackEntrepreneur In ResidenceFounded menlomicro-bg

Same school

Also attended Universidad de Chile95

Emmi KaipioDirector of Sprints at Emerald Technology Ventures AgMacarena LiuCo-Founder and General Partner at DrivenEmilio Erazo-FischerOperating Partner at Asabys PartnersSophie WatsonVenture Debt Fund at Salica InvestmentsIgnacio GallegosAdvisor at Curiosity VCMatias AlcaldeCFO at 30N Ventures

+ 89 more

Shared employers

Also worked at GIVAX, Inc.3

Laura TadvalkarManaging Director, Venture at RA CapitalFanny CavaliéChief Executive Officer at NorthLinks BioJohn PattonScientific Co-Founder at GIVAX

Also worked at Curevo Vaccine5

Kabeer AzizCo-Founder and Partner at Adjuvant CapitalTal ZaksPartner at OrbiMedDavid MillerExecutive Officer, Director at Alpine Immune SciencesGeorge SimeonCEO at Curevo VaccineGuy De La RosaCMO at Curevo Vaccine

Also worked at Vaxess Technologies6

Johannes FruehaufGeneral Partner at Mission BiocapitalAaron SandoskiMCF Partner at SV Health InvestorsRachel ShaCEO at terrestrialPurnanand SarmaExecutive Officer, Director at ImmunomeMatthew DirckxExecutive Officer at Vaxess Technologies, Inc.Lynda TusseyExecutive Officer at Vaxess Technologies, Inc.

Also worked at Sanofi Pasteur248

Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures

+ 242 more